Pantoprazol Micro Labs (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Micro Labs, is a proton pump inhibitor presented as a solid dosage form for oral use. It reduces stomach acid production and is used to manage acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoprazol Micro Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Micro Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Micro Labs is a proton‑induced acid‑secretion inhibitor that acts on the gastric parietal cell H⁺‑K⁺‑ATPase system.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Peptic ulcer disease (duodenal and gastric): supports ulcer healing and symptom relief. - NSAID‑induced gastropathy: reduces risk of ulcer formation in chronic NSAID users.

Pantoprazol Micro Labs may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache  - Diarrhea  - Nausea  - Abdominal pain  - Flatulence  - Constipation 

Serious or Rare Side Effects: - Acute interstitial nephritis  - Severe allergic reactions (anaphylaxis, angio‑edema)  - Clostridioides difficile‑associated colitis  - Low magnesium (hypomagnesemia)  - Fracture risk  - Vitamin B12 deficiency 

When ​  ​       ​  ​     …  ... 

-    …  … 

The    …  … 

    …  …